FdaApplication
ANDA 203007
Identifiers
- fda_app_no: ANDA203007
Properties
| Property | Value |
|---|---|
| applicant_name | NATCO PHARMA LTD |
| application_type | ANDA |
| approval_date | 2020-09-29 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LAPATINIB DITOSYLATE | LAPATINIB DITOSYLATE | EQ 250MG BASE | TABLET;ORAL |
1 product